Skip to Main Content
Wyss Institute
Menu
Search Site
How We Work
Technologies
Collaboration
Team
News
Search
Search results
9 Results for 'Cardiovascular Dysfunction'
Technologies
(1)
Collaborations
(0)
Team
(0)
News
(7)
Events
(1)
Multimedia
(0)
Publications
(0)
Jobs
(0)
Technologies
1
Rapid Metabolite-Sensing System for Blood Lactate
In emergency medicine, blood lactate levels are a reliable real-time indicator of the severity and mortality risk of conditions that occur as a result of poor blood circulation and oxygen supply to organs and tissues (hypoperfusion), such as in patients with sepsis, cardiac arrest, stroke, major trauma, cystic fibrosis and other conditions. Lactate levels also...
News
7
View all
Translation News
Alkem licenses technology from Harvard University, aiming to treat ischemic injury and vascular diseases
February 10, 2022
Press Release
Another trick up the immune system’s sleeve: regrowing blood vessels
July 31, 2019
Press Release
Platelet “Decoys” Outsmart Both Clots and Cancer
February 13, 2019
Events
1
Nov 10, 2016,
2:00pm - 3:00pm
Lecture
Add to Calendar
iCalendar
Google Calendar
Outlook
Mannose Binding Lectin and Cardiovascular Dysfunction
The innate immune system plays an important role in host defense. Over 15 years ago, we changed the paradigm of the ischemia/reperfusion injury field by identifying mannose binding lectin (MBL) as the initiator of complement activation in vitro and in vivo. Since that time, we have found that MBL plays an important role in many...
Free and open to public
Close search results
How We Work
Technologies
Collaboration
Team
News
Contact
Careers
Events
Multimedia
Resources
Publications
Impact Report
Wiki Login
Close menu